AWM
PACB icon

Avior Wealth Management’s Pacific Biosciences PACB Stock Holding History

Avior Wealth Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-51
Closed -$191 – 3277
2024
Q1 		$191 Buy
+51
New +$299 ﹤0.01% 2887
2021
Q4 		– Sell
-9,708
Closed -$248K – 1179
2021
Q3 		$248K Hold
9,708
– – 0.02% 399
2021
Q2 		$339K Buy
9,708
+2,702
+39% +$78.6K 0.03% 349
2021
Q1 		$233K Buy
+7,006
New +$245K 0.02% 385

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Avior Wealth Management's PACB Position: Q2 2024 in Review

Avior Wealth Management sold out of Pacific Biosciences (PACB) in Q2 2024, closing a stake of 51 shares — an estimated $191 sold.

Avior Wealth Management first reported a position in PACB in Q1 2021 and held it in 4 quarters. The position peaked at $339K in Q2 2021. 228 funds tracked by Wall St. Rank hold PACB as of Q2 2024.

  • Avior Wealth Management reported no remaining Pacific Biosciences position as of Q2 2024 after selling out during the quarter.
  • Avior Wealth Management sold 51 Pacific Biosciences shares in Q2 2024, an estimated $191.
  • Avior Wealth Management first reported a position in Pacific Biosciences in Q1 2021 and held it in 4 quarters.
  • Avior Wealth Management's Pacific Biosciences position peaked at $339K in Q2 2021.
  • 228 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2024.

Based on Avior Wealth Management's 13F filing for Q2 2024, filed 13 Aug 2024.